These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7019034)

  • 41. Further evidence for functional heterogeneity of adipocyte insulin receptors.
    Olefsky JM; Chang H
    Endocrinology; 1979 Feb; 104(2):462-6. PubMed ID: 446370
    [No Abstract]   [Full Text] [Related]  

  • 42. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlation of lipid peroxidation intensity and insulin reception in adipocytes].
    Ivanov VV; Stennikova MP
    Vopr Med Khim; 1993; 39(4):23-5. PubMed ID: 8379107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid down regulation of insulin receptors in adipocytes artifact of the incubation buffer.
    Rennie P; Gliemann J
    Biochem Biophys Res Commun; 1981 Oct; 102(3):824-31. PubMed ID: 7030346
    [No Abstract]   [Full Text] [Related]  

  • 45. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M; Haneda M; Maegawa H; Watanabe N; Takada Y; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1984 Feb; 119(1):49-57. PubMed ID: 6367745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM; Piron MA; De Meyts P
    Diabetes Care; 1981; 4(2):209-14. PubMed ID: 7011729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-linked [DAlaA1]Insulins. Evidence for a change in the conformation of the insulin monomer at its receptor.
    Saunders D; Freude K
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):655-9. PubMed ID: 7049891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of biosynthetic human diarginylinsulin.
    Zeuzem S; Stahl E; Jungmann E; Zoltobrocki M; Schöffling K; Caspary WF
    Diabetologia; 1990 Feb; 33(2):65-71. PubMed ID: 2184062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor binding studies on A1-(2-nitro-4-trimethylammoniophenyl)insulin.
    Lesniak M; Gliemann J; Roth J; Easter BR; Sutton DA; Drewes SE
    Hoppe Seylers Z Physiol Chem; 1979 Mar; 360(3):467-71. PubMed ID: 437696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of insulin receptors during preadipocyte differentiation.
    Reed BC; Lane MD
    Adv Enzyme Regul; 1980; 18():97-117. PubMed ID: 7004132
    [No Abstract]   [Full Text] [Related]  

  • 51. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.
    Corporeau C; Foll CL; Taouis M; Gouygou JP; Bergé JP; Delarue J
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E78-E86. PubMed ID: 16339925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of insulin degradation by isolated rat adipocytes.
    Olefsky JM; Saekow M
    Mol Cell Biochem; 1982 Aug; 47(1):23-9. PubMed ID: 6752691
    [No Abstract]   [Full Text] [Related]  

  • 53. [Regulation of insulin receptor expression and its place in the mechanism of insulin action].
    Bezdrobnyĭ IuV
    Usp Sovrem Biol; 1981; 92(1):35-48. PubMed ID: 7027664
    [No Abstract]   [Full Text] [Related]  

  • 54. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):458-61. PubMed ID: 2643113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.
    Wang CC; Goldfine ID; Fujita-Yamaguchi Y; Gattner HG; Brandenburg D; De Meyts P
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8400-4. PubMed ID: 3054887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography.
    Frank BH; Peavy DE; Hooker CS; Duckworth WC
    Diabetes; 1983 Aug; 32(8):705-11. PubMed ID: 6347767
    [No Abstract]   [Full Text] [Related]  

  • 57. [B22-D-arginine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1449-60. PubMed ID: 6761262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and properties of citraconylinsulins.
    Naithani VK; Gattner HG
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1443-8. PubMed ID: 6761261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of muscarinic M-3 receptor may decrease glucose uptake and lipolysis in adipose tissue of rats.
    Yang TT; Chang CK; Tsao CW; Hsu YM; Hsu CT; Cheng JT
    Neurosci Lett; 2009 Feb; 451(1):57-9. PubMed ID: 19111904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endotoxin-enhanced secretion of macrophage insulin-like activity.
    Filkins JP
    J Reticuloendothel Soc; 1980 May; 27(5):507-11. PubMed ID: 6989995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.